Wordt geladen...
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Telomerase reverse transcriptase (TERT) promoter mutations were recently shown to drive telomerase activity in various cancer types, including medulloblastoma. However, the clinical and biological implications of TERT mutations in medulloblastoma have not been described. Hence, we sought to describe...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Berlin Heidelberg
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3830749/ https://ncbi.nlm.nih.gov/pubmed/24174164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00401-013-1198-2 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|